XENE

Xenon Pharmaceuticals Inc (XENE)

US
$ 30.490.1%

Price Chart

Key Statistics

Market Cap
$ 2.48B
P/E Ratio
0.00
Revenue (TTM)
$ 7.5M
Volume
1.86M
52W High
$ 46.00
52W Low
$ 26.74
Dividend Yield
0.00%
Beta
1.10

Technicals

50-Day MA
32.7568
200-Day MA
37.9748
52 Week High
46
52 Week Low
26.74

About XENE

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric di.

Employees
316
Headquarters
Burnaby, BC
CEO
Ms. Sherry Aulin C.A., CPA

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg